< Back to previous page
Researcher
Toon Van Gorp
- Disciplines:Cancer diagnosis, Cancer therapy, Oncological surgery, Cancer biology
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Oct 2019 → 30 Sep 2022
Projects
1 - 5 of 5
- Liquid biopsy and HRD testing in ovarian cancerFrom4 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PPP2R1A as a new biomarker in type-II endometrial cancers.From1 Jan 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Predictive genetic markers for targeted therapy in gynaecological cancers: bridging the gap between “one-size-fits-all” and personalized treatmentFrom8 Oct 2020 → 30 Sep 2022Funding: BOF - projects
- Predictive genetic markers in gynaecological cancers: how to improve targeted therapy.From1 Oct 2020 → TodayFunding: FWO fundamental clinical research fellowship
- Predictive genetic markers for targeted therapy in gynaecological malignancies: bridging the gap between “one-size-fits-all” and more personalised treatment approach.From1 Aug 2019 → 11 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
101 - 110 of 140
- Are serum HE4 or ROMA scores useful to experienced examiners to improve characterization of adnexal masses after transvaginal ultrasonography?(2014)
Authors: Toon Van Gorp, Tom Bourne, Ignace Vergote, Ben Van Calster, Dirk Timmerman
Pages: 89 - 97 - Angiosarcomas of Primary Gynecologic Origin A Clinicopathologic Review and Quantitative Analysis of Survival(2014)
Authors: Toon Van Gorp
Pages: 4 - 12 - The role of surgery in the management of patients with platinum-sensitive recurrent ovarian cancer: Survey among Dutch gynecologists and medical oncologists(2013)
Authors: Toon Van Gorp
Pages: 561 - 566 - The value of imaging of the lungs in the diagnostic workup of patients with endometrial cancer(2013)
Authors: Toon Van Gorp
Pages: 147 - 150 - The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - Analysis of patient data in the prospective OVCAD study(2013)
Authors: Toon Van Gorp, Ignace Vergote
Pages: 15 - 20 - Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm(2013)
Authors: Toon Van Gorp, Ignace Vergote, Tom Bourne, Ben Van Calster, Dirk Timmerman
Pages: 398 - 9 - A comparison between an ultrasound based prediction model (LR2) and the Risk of Ovarian Malignancy Algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass(2013)
Authors: Toon Van Gorp, Kirsten Van Hoorde, Ignace Vergote, Tom Bourne, Dirk Timmerman, Ben Van Calster
Pages: 377 - 83 - A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - A study of the OVCAD consortium(2013)
Authors: Ignace Vergote, Toon Van Gorp
Pages: 178 - 178 - Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium(2012)
Authors: Toon Van Gorp, Ignace Vergote
- Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses(2012)
Authors: Toon Van Gorp, Ben Van Calster, Frédéric Amant, Dirk Timmerman, Ignace Vergote
Pages: 1649 - 56